Journal Article Research Support, Non-U.S. Gov't Epublish 57 citations
PubMed: 35976645 DOI: 10.1001/jamanetworkopen.2022.27241
Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity.
JAMA Netw Open 5(8):e2227241
Authors: Sandy Y Joung, Joseph E Ebinger, Nancy Sun, Yunxian Liu, Min Wu, Amber B Tang, John C Prostko, Edwin C Frias, James L Stewart, Kimia Sobhani, Susan Cheng
Affiliations
- Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.
- David Geffen School of Medicine, UCLA (University of California, Los Angeles).
- Applied Research and Technology, Abbott Diagnostics, Abbott Park, Illinois.
- Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
Abstract
Importance
Some individuals who were infected by the SARS-CoV-2 Omicron variant may have been completely unaware of their infectious status while the virus was actively transmissible.
Objective
To examine awareness of infectious status among individuals during the recent Omicron variant surge in a diverse and populous urban region of Los Angeles County.
Design, Setting, and Participants
This cohort study analyzed the records of adult employees and patients of an academic medical center who were enrolled in a longitudinal COVID-19 serological study in Los Angeles County, California. These participants had 2 or more serial anti-nucleocapsid IgG (IgG-N) antibody measurements at least 1 month apart, with the first occurring after the end of a regional Delta variant surge (September 15, 2021) and a subsequent one occurring after the start of a regional Omicron variant surge (December 15, 2021). Adults with evidence of new SARS-CoV-2 infection occurring during the Omicron variant surge period through May 4, 2022, were included in the present study sample.
Exposures
Recent Omicron variant infection as evidenced by SARS-CoV-2 seroconversion.
Main Outcomes and Measures
Awareness of recent SARS-CoV-2 infection was ascertained from review of self-reported health updates, medical records, and COVID-19 testing data.
Results
Of the 210 participants (median [range] age, 51 (23-84) years; 136 women [65%]) with serological evidence of recent Omicron variant infection, 44% (92) demonstrated awareness of any recent Omicron variant infection and 56% (118) reported being unaware of their infectious status. Among those who were unaware, 10% (12 of 118) reported having had any symptoms, which they attributed to a common cold or other non-SARS-CoV-2 infection. In multivariable analyses that accounted for demographic and clinical characteristics, participants who were health care employees of the medical center were more likely than nonemployees to be aware of their recent Omicron variant infection (adjusted odds ratio, 2.46; 95% CI, 1.30-4.65).
Conclusions and Relevance
Results of this study suggest that more than half of adults with recent Omicron variant infection were unaware of their infectious status and that awareness was higher among health care employees than nonemployees, yet still low overall. Unawareness may be a highly prevalent factor associated with rapid person-to-person transmission within communities.
MeSH
Research Design, Sars-Cov-2, Clinical Medicine, Covid-19, Records, Severe Acute Respiratory Syndrome-Related Coronavirus, Infections
Cited by
- The Influence of Comorbidities, General Health Status, and Self-Care Self-Efficacy on COVID-19 Symptoms During the Omicron Wave. Cureus, 2023
- Sex differences in adenosine deaminase activity associate with disparities in SARS-CoV-2 innate immunity. iScience, 2025
- Impact of Cancer Subtype and Cancer Therapy Exposures on SARS-CoV-2 Outcomes in the Omicron and Subvariant Era. Cancer Med, 2025
- Proportions of US Blood Donors With Serological Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections Who Reported Survey-Based Diagnosed Infections During July 2020-December 2022. Open Forum Infect Dis, 2025
- Concurrent Administration of COVID-19 and Influenza Vaccines Enhances Spike-Specific Antibody Responses. Open Forum Infect Dis, 2024
- The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting. PLOS Glob Public Health, 2025
- COVID-19 in Japan during 2020-2022: Characteristics, responses, and implications for the health care system. J Glob Health, 2022
- Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada. CMAJ, 2022
- COVID-19 passenger screening to reduce travel risk and translocation of disease. Epidemiol Infect, 2024
- Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 ("Omicron") SARS-CoV-2 Variant Wave. Cancers (Basel), 2022
- Chronic Pulmonary Manifestations of COVID-19 Infection: Imaging Evaluation. Radiology, 2023
- Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational study. EBioMedicine, 2023
- Epidemiological and clinical features of COVID-19 inpatients in Changsha, China: A retrospective study from 2020 to 2022. Heliyon, 2023
- Comparison of six COVID-19 serology assays for detection of antibodies from patients infected with ancestral and a spectrum of SARS-CoV-2 variants. Access Microbiol, 2025
- Opportunities and Challenges in Using Electronic Health Record Systems to Study Postacute Sequelae of SARS-CoV-2 Infection: Insights From the NIH RECOVER Initiative. J Med Internet Res, 2025
- Long-term durability of antibody responses after SARS-CoV-2 vaccination and influencing factors. J Intern Med, 2023
- Perceived Hospital Stress, Severe Acute Respiratory Syndrome Coronavirus 2 Activity, and Care Process Temporal Variance During the COVID-19 Pandemic. Crit Care Med, 2023
- Assessing the post hoc effectiveness of tixagevimab-cilgavimab for prevention of SARS-CoV-2 infections in solid organ transplant recipients. Transpl Infect Dis, 2024
- Diverse immune responses in vaccinated individuals with and without symptoms after omicron exposure during the recent outbreak in Guangzhou, China. Heliyon, 2024
- Suppression of the alpha, delta, and omicron variants of SARS-Cov-2 in Taiwan. PLoS One, 2024